Results 151 to 160 of about 15,755 (201)

Case report: anti-GAD65 antibody-associated epilepsy as the primary manifestation of chronic graft-versus-host disease. [PDF]

Ann Hematol
Yang S, Gu P, Tian J, Tang X, Xue Q.
europepmc   +1 more source

CD38 as an immunotherapeutic target in multiple myeloma [PDF]

, 2018
Boccadoro, M., Bonello, F., Cerrato, C., D'Agostino, M., Gay, F., Moscvin, M.   +5 more
core   +1 more source

IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM. [PDF]

Blood Adv
Maclachlan KH, Tan CR, Shekarkhand T, Rueda C, Derkach A, Hashmi H, Hassoun H, Shah UA, Hultcrantz M, Lesokhin AM, Mailankody S, Maura F, Merz M, Firestone R, Jurgens EM, Miller KC, Rajeeve S, Giralt S, Shah GL, Scordo M, Landau HJ, Zhang Y, Cimera R, Arcila ME, Korde N, Usmani SZ.   +25 more
europepmc   +1 more source

Abordagem do Mieloma Múltiplo em Doentes Jovens - A propósito de um caso clínico [PDF]

, 2014
Inês Filipa Monteiro Cordeiro Ferro
core  

Inconsistency between serum IgG κ and glomerular IgA λ chain types in proliferative glomerulonephritis with monoclonal deposits successfully treated with daratumumab-based therapy. [PDF]

Medicine (Baltimore)
Chen H, Chen D, Zhang G, Cheng M, Jin J, Niu Z, Zhu R, Guo L, Wang J, Bai Y, Xu J, Cheng Z.   +11 more
europepmc   +1 more source

Daratumumab for Treatment of Refractory Podocytopathy: A Case Report. [PDF]

Kidney Med
Curto A, Martinez Leon VJ, Geara AS.
europepmc   +1 more source

Acute Rejection With DSA-Negative Severe Microvascular Inflammation in a Kidney Transplant Recipient With an Isolated DPB1*04-Mismatch Successfully Stabilised With Daratumumab. [PDF]

HLA
Knödl L, Büttner-Herold M, Götz M, Luber M, Spriewald B, Oellerich M, Beck J, Banas B, Zecher D.   +8 more
europepmc   +1 more source

Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials. [PDF]

Sci Rep
Abuhelwa AY, Almansour SA, Al-Shamsi HO, Abuhelwa Z, Alqudah MAY, Bustanji Y, Semreen MH, Alzoubi KH, Modi ND, McKinnon RA, Sorich MJ, Hopkins AM.   +11 more
europepmc   +1 more source

Clinical significance of t(11;14) translocation in systemic AL amyloidosis in the era of daratumumab therapy. [PDF]

Clin Exp Med
Nishimura N, Kawano Y, Yasunaga JI.
europepmc   +1 more source

Daratumumab combined with anti-CD20 therapy in pediatric and adult refractory idiopathic nephrotic syndrome: single-center experience. [PDF]

Front Immunol
Naciri Bennani H, Sandaye T, Charroyer Q, Etangsale A, Vacher Coponat H, Julien M, Mear V, Dunand O, Di Ascia L.   +8 more
europepmc   +1 more source